Dec

9

There are many approaches to measuring the health of the stock market:

Readers can feel free to suggest a few others from the endless list.

I have long thought an alternate approach might be apt. The basic idea is to see how individual stocks respond to day-to-day things that are part of the fray.

Start with earnings reports. How do companies perform on the day they report earnings, taking into account how the earnings compare to expectations, and how the expectations are changing? Then expand to specialized things that are always happening. When big company like Pfizer loses a product and the stock drops 15% at the opening, as it did on Dec. 4, how quickly is the drop retraced over the next one to four days? What is the average premium on acquisitions, and how frequent are they? What is the daily volume of reported insider buys and sells, and how did the stocks perform in the days before the purchases and disclosures? What is the relation of value to growth on a particular day, and of big versus small (this is the easiest question because a glance at a few indexes provides the answer.) How many stocks close at various high or low parts of their ranges, relative to the stock market as a whole? How did the Value Line Group 1 champs do on the days preceding their earnings reports? How are the big moves in big option stocks distributed?

It would be laborious to construct such a series, and it would require skill to use it for estimates. The beauty is that because of the cost and extent of the input required, one might come up with something that actually has not already been discounted by the hundreds of thousands of excellent minds always looking for an edge.


Comments

Name

Email

Website

Speak your mind

Archives

Resources & Links

Search